We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · November 25, 2021

Ornithine Phenylacetate Is Safe and Effective for Overt Hepatic Encephalopathy

Clinical Gastroenterology and Hepatology


Additional Info

Clinical Gastroenterology and Hepatology
Efficacy and Safety of Ornithine Phenylacetate for Treating Overt Hepatic Encephalopathy in a Randomized Trial
Clin. Gastroenterol. Hepatol. 2021 Dec 01;19(12)2626-2635.e7, RS Rahimi, R Safadi, D Thabut, KR Bhamidimarri, N Pyrsopoulos, A Potthoff, S Bukofzer, JS Bajaj

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading